Modulatory effects of methyl gallate on the inflammatory response in gout arthritis via P2X7 receptor
Year: 2026
Type: article
Abstract: Gout is an inflammatory disease caused by monosodium urate (MSU) crystal deposition, triggering NLRP3 inflammasome activation, interleukin-1β (IL-1β) release, and P2X7 receptor-mediated amplification of inflammation. This study evaluated the anti-inflammatory effects of methyl gallate (MG) and its interaction with the P2X7 receptor. MG reduced IL-1β production in activated macrophages, inhibited P2X7-dependent membrane pore formation, and produced effects similar to those of the selective P2X7 antagonist A740003. In a murine gout model, MG decreased joint edema, leukocyte accumulation, and IL-1β levels. Computational analyses demonstrated stable MG binding to P2X7, highlighting its potential as a therapeutic candidate for gout treatment.
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Awards: G1294967738, G1339782116, G1885900929, G202768474, G2599378469, G2646829352, G2772038414, G2875288817, G3041299565, G310697676, G321761023, G3374542901, G3566161998, G3867220333, G394841172, G401495898, G4170649775, G4539897318, G4785167260, G4938836052, G5652243749, G5938601676, G6053777215, G6082397829, G6107052495, G6863166971, G6867583126, G6949143738, G6949772428, G7081391321, G738631893, G7467077513, G8389109314, G8522711164
OpenAlex ID: W7204550441
